Prior Anti-TNF-Alpha Exposure Is Associated with Ustekinumab Dose Escalation in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Tran, Nancy [1 ]
Lavergne, Alexa [1 ]
Scherl, Ellen [1 ]
Longman, Randy [1 ]
Lukin, Dana [1 ]
机构：
[1] Weill Cornell Med, Jill Roberts Ctr Inflammatory Bowel Dis, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1191
引用
收藏
页码：S907 / S908
页数：2
相关论文
共 50 条
  • [1] Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease
    Lucas Ramos, Javier
    Suarez Ferrer, Cristina
    Poza Cordon, Joaquin
    Sanchez Azofra, Maria
    Rueda Garcia, Jose Luis
    Martin Arranz, Eduardo
    Yebra Carmona, Jorge
    Andaluz Garcia, Irene
    Martin Arranz, Maria Dolores
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (05): : 337 - 345
  • [2] Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease
    Choi, David K.
    Puangampai, Archariya
    Rubin, David T.
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1279 - 1280
  • [3] Predictors and frequency of anti-TNF dose escalation in patients with inflammatory bowel disease
    Viazis, N.
    Koukouratos, T.
    Anastasiou, J.
    Saprikis, E.
    Kechagias, G.
    Katopodi, K.
    Mela, M.
    Karamanolis, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S224 - S224
  • [4] Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease
    Lucendo, Alfredo J.
    Roncero, Oscar
    Teresa Serrano-Duenas, Maria
    Hervías, Daniel
    Miguel Alcazar, Luis
    Miriam-Ruiz-Ponce
    Verdejo, Cristina
    Laserna-Mendieta, Emilio
    Lorente, Rufo
    Arias, Angel
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (04) : 400 - 407
  • [5] PREDICTORS AND OUTCOMES OF USTEKINUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE
    Petrov, Jessica C.
    Fine, Sean
    Al Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S824 - S824
  • [6] Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
    Beigel, Florian
    Deml, Matthias
    Schnitzler, Fabian
    Breiteneicher, Simone
    Goeke, Burkhard
    Ochsenkuehn, Thomas
    Brand, Stephan
    [J]. PLOS ONE, 2014, 9 (06):
  • [7] Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease
    Yzet, Clara
    Dupas, Jean-Louis
    Fumery, Mathurin
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05): : 748 - 749
  • [8] Immunomodulators provide no reduction in loss of response for inflammatory bowel disease patients starting anti-TNF-alpha therapy
    Varma, P.
    Yeaman, F.
    Holt, D.
    Moore, G.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 140 - 141
  • [9] Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
    Bokemeyer, Arne
    Tentrop, Nicolas
    Barth, Peter J.
    Lenze, Frank
    Hengst, Karin
    Kleinheinz, Johannes
    Bettenworth, Dominik
    [J]. BMC GASTROENTEROLOGY, 2018, 18
  • [10] Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
    Arne Bokemeyer
    Nicolas Tentrop
    Peter J. Barth
    Frank Lenze
    Karin Hengst
    Johannes Kleinheinz
    Dominik Bettenworth
    [J]. BMC Gastroenterology, 18
12345